E31.2 Category · further specificity required Multiple endocrine neoplasia [MEN] syndromes
ICD-10-CM E31.2 identifies “Multiple endocrine neoplasia [MEN] syndromes” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Inclusion terms1
Multiple endocrine adenomatosis
Code also1
any associated malignancies and other conditions associated with the syndromes
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E20-E35 · Disorders of other endocrine glands (E20-E35)
E31 · Polyglandular dysfunction
More specific codes
Official index references
References from other codes (8)
Code also · any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Code also · any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Excludes 1 · multiple endocrine adenomatosis (E31.2-)
Excludes 1 · multiple endocrine neoplasia (E31.2-)
Excludes 1 · multiple endocrine adenomatosis (E31.2-)
Excludes 1 · multiple endocrine neoplasia (E31.2-)
Excludes 2 · multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Excludes 1 · multiple endocrine neoplasia [MEN] syndromes (E31.2-)
History
Code history
No recorded change since first observation
Effective from
- First observed
Multiple endocrine neoplasia [MEN] syndromes
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.